NIH research funding drops $1B under Trump administration

Updated on: March 29,2025 0

NIH research funding drops $1B under Trump administration

Updated on:March 29,2025 0

Cancer drug eliminates aggressive cancers in Phase I trial

Updated on: September 04,2025 0

Cancer drug eliminates aggressive cancers in Phase I trial

Updated on:September 04,2025 0

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

Updated on: October 02,2025 0

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

Updated on:October 02,2025 0

California clinicians boost buprenorphine prescriptions, aiding recovery efforts

Updated on: March 28,2025 0

California clinicians boost buprenorphine prescriptions, aiding recovery efforts

Updated on:March 28,2025 0

Talazoparib and enzalutamide tied to improved overall survival in metastatic prostate cancer

Updated on: March 28,2025 0

Talazoparib and enzalutamide tied to improved overall survival in metastatic prostate cancer

Updated on:March 28,2025 0

Drug therapy lenacapavir may effectively control HIV in Uganda

Updated on: March 29,2025 0

Drug therapy lenacapavir may effectively control HIV in Uganda

Updated on:March 29,2025 0

Hyperbaric oxygen treatment helps cancer patients reclaim normal life after radiation side effects

Updated on: May 19,2025 0

Hyperbaric oxygen treatment helps cancer patients reclaim normal life after radiation side effects

Updated on:May 19,2025 0

Blood-based screening has acceptable accuracy for colorectal cancer detection

Updated on: July 12,2025 0

Blood-based screening has acceptable accuracy for colorectal cancer detection

Updated on:July 12,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on: October 04,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on:October 04,2025 0

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on: October 04,2025 0

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on:October 04,2025 0